FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2789079069> ?p ?o ?g. }

• W2789079069 endingPage "453" @default.
• W2789079069 startingPage "434" @default.
• W2789079069 abstract "•Echocardiography is key to determining mitral valve pathology and suitability for percutaneous repair. •Two-dimensional and 3D echocardiography is invaluable for MitraClip procedural guidance, confirming success, and exclusion of complications. •The role of interventional echocardiography will increase with the development of novel new devices. Percutaneous intervention for mitral valve (MV) disease has been established as an alternative to open surgical MV repair in patients with prohibitive surgical risk. Multiple percutaneous approaches have been described and are in various stages of development. Edge-to-edge leaflet plication with the MitraClip (Abbott, Menlo Park, CA) is currently the only Food and Drug Administration-approved device specifically for primary or degenerative lesions. Use of the edge-to-edge clip for secondary mitral regurgitation is currently under investigation and may result in expanded indications. Echocardiography has significantly increased our understanding of the anatomy of the MV and provided us with the ability to classify and quantify the associated mitral regurgitation. For percutaneous interventions of the MV, transesophageal echocardiography imaging is used for patient screening, intraprocedural guidance, and confirmation of the result. Optimal outcomes require the echocardiographer and the proceduralist to have a thorough understanding of intra-atrial septal and MV anatomy, as well as an appreciation for the key points and potential pitfalls of each of the procedural steps. With increasing experience, more complex valvular pathology can be successfully percutaneously treated. In addition to two-dimensional echocardiography, advances in three-dimensional echocardiography and fusion imaging will continue to support the refinement of current technologies, the expansion of clinical applications, and the development of novel devices. Percutaneous intervention for mitral valve (MV) disease has been established as an alternative to open surgical MV repair in patients with prohibitive surgical risk. Multiple percutaneous approaches have been described and are in various stages of development. Edge-to-edge leaflet plication with the MitraClip (Abbott, Menlo Park, CA) is currently the only Food and Drug Administration-approved device specifically for primary or degenerative lesions. Use of the edge-to-edge clip for secondary mitral regurgitation is currently under investigation and may result in expanded indications. Echocardiography has significantly increased our understanding of the anatomy of the MV and provided us with the ability to classify and quantify the associated mitral regurgitation. For percutaneous interventions of the MV, transesophageal echocardiography imaging is used for patient screening, intraprocedural guidance, and confirmation of the result. Optimal outcomes require the echocardiographer and the proceduralist to have a thorough understanding of intra-atrial septal and MV anatomy, as well as an appreciation for the key points and potential pitfalls of each of the procedural steps. With increasing experience, more complex valvular pathology can be successfully percutaneously treated. In addition to two-dimensional echocardiography, advances in three-dimensional echocardiography and fusion imaging will continue to support the refinement of current technologies, the expansion of clinical applications, and the development of novel devices." @default.
• W2789079069 created "2018-03-06" @default.
• W2789079069 creator A5013503608 @default.
• W2789079069 creator A5016249345 @default.
• W2789079069 creator A5039178895 @default.
• W2789079069 creator A5053490576 @default.
• W2789079069 creator A5056409654 @default.
• W2789079069 creator A5082755751 @default.
• W2789079069 date "2018-04-01" @default.
• W2789079069 modified "2023-10-03" @default.
• W2789079069 title "Transcatheter Mitral Valve Repair Using the Edge-to-Edge Clip" @default.
• W2789079069 cites W125403891 @default.
• W2789079069 cites W1505501470 @default.
• W2789079069 cites W1606134853 @default.
• W2789079069 cites W163303675 @default.
• W2789079069 cites W172729246 @default.
• W2789079069 cites W1892343481 @default.
• W2789079069 cites W1964083569 @default.
• W2789079069 cites W1968069443 @default.
• W2789079069 cites W1968600609 @default.
• W2789079069 cites W1969417469 @default.
• W2789079069 cites W1974380291 @default.
• W2789079069 cites W1978166365 @default.
• W2789079069 cites W1988335649 @default.
• W2789079069 cites W1989544375 @default.
• W2789079069 cites W1993351891 @default.
• W2789079069 cites W1994078669 @default.
• W2789079069 cites W2005359002 @default.
• W2789079069 cites W2009085855 @default.
• W2789079069 cites W2022164691 @default.
• W2789079069 cites W2024622102 @default.
• W2789079069 cites W203013263 @default.
• W2789079069 cites W2032513204 @default.
• W2789079069 cites W2039023088 @default.
• W2789079069 cites W2040230057 @default.
• W2789079069 cites W2046367523 @default.
• W2789079069 cites W2049493294 @default.
• W2789079069 cites W2072681756 @default.
• W2789079069 cites W2082339890 @default.
• W2789079069 cites W2085935317 @default.
• W2789079069 cites W2087201631 @default.
• W2789079069 cites W2088642712 @default.
• W2789079069 cites W2091781831 @default.
• W2789079069 cites W2101825249 @default.
• W2789079069 cites W2104001258 @default.
• W2789079069 cites W2104724093 @default.
• W2789079069 cites W2112418780 @default.
• W2789079069 cites W2115263501 @default.
• W2789079069 cites W2119499625 @default.
• W2789079069 cites W2130007894 @default.
• W2789079069 cites W2130181775 @default.
• W2789079069 cites W2138474182 @default.
• W2789079069 cites W2139370285 @default.
• W2789079069 cites W2140596132 @default.
• W2789079069 cites W2140809814 @default.
• W2789079069 cites W2144039883 @default.
• W2789079069 cites W2153290338 @default.
• W2789079069 cites W2172703205 @default.
• W2789079069 cites W2179188561 @default.
• W2789079069 cites W2191399290 @default.
• W2789079069 cites W2200415095 @default.
• W2789079069 cites W2204366991 @default.
• W2789079069 cites W2233452031 @default.
• W2789079069 cites W2312170335 @default.
• W2789079069 cites W2318670284 @default.
• W2789079069 cites W2325575294 @default.
• W2789079069 cites W2333388449 @default.
• W2789079069 cites W2337524670 @default.
• W2789079069 cites W2404608663 @default.
• W2789079069 cites W2468678428 @default.
• W2789079069 cites W2529225322 @default.
• W2789079069 cites W2529391446 @default.
• W2789079069 cites W2537782084 @default.
• W2789079069 cites W2548861862 @default.
• W2789079069 cites W2549362112 @default.
• W2789079069 cites W2559366242 @default.
• W2789079069 cites W2561943656 @default.
• W2789079069 cites W2564596881 @default.
• W2789079069 cites W2581357889 @default.
• W2789079069 cites W2585723394 @default.
• W2789079069 cites W2596797126 @default.
• W2789079069 cites W2596816418 @default.
• W2789079069 cites W2599929763 @default.
• W2789079069 cites W2602515193 @default.
• W2789079069 cites W2610593164 @default.
• W2789079069 cites W4205993996 @default.
• W2789079069 cites W52361890 @default.
• W2789079069 cites W882773571 @default.
• W2789079069 doi "https://doi.org/10.1016/j.echo.2018.01.012" @default.
• W2789079069 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29482977" @default.
• W2789079069 hasPublicationYear "2018" @default.
• W2789079069 type Work @default.
• W2789079069 sameAs 2789079069 @default.
• W2789079069 citedByCount "34" @default.
• W2789079069 countsByYear W27890790692018 @default.
• W2789079069 countsByYear W27890790692019 @default.
• W2789079069 countsByYear W27890790692020 @default.
• W2789079069 countsByYear W27890790692021 @default.

• next